Skip to content

Patient Response to Spinal Manipulation - Pilot Study

Pilot for Patient Response to Spinal Manipulation (PRiSM)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01562756
Acronym
PRiSM
Enrollment
6
Registered
2012-03-26
Start date
2012-02-29
Completion date
2012-05-31
Last updated
2017-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Brief summary

In collaboration with the University of Iowa, the Palmer Center for Chiropractic Research will conduct a pilot study for the purposes of testing equipment, finalizing data collection protocol, and training study personnel before conducting the full-scale trial.

Detailed description

In collaboration with the University of Iowa, the Palmer Center for Chiropractic Research will conduct a pilot study for the purposes of testing equipment, finalizing the data collection protocol, and training study personnel before conducting the full-scale trial. Only feasibility data will be collected and reported for this pilot study. The full-scale trial, titled as Patient response to spinal manipulation (Trial registration: NCT01670292 on clinicaltrials.gov), is the Project 1 of the Developmental Center for Clinical and Translational Science in Chiropractic (Award No. U19AT004663). In the current pilot study, we test how research clinicians can treat patients under study measurement conditions and with equipment resulting in modified treatment procedures. This pilot study will also test spinal stiffness using 3 different methods on 2 study visits. We will also assess the function of low back muscles during standing and while bending forward on 2 visits. These measurements include placing sensors on the back with tape and measuring the electrical activity of low back muscles. Participants with low back pain are treated with side-lying high-velocity low-amplitude spinal manipulation by experienced research clinicians who are doctors of chiropractic. Specifically, we will recruit 6 participants who are 21 - 64 years old and have had low back pain for at least 3 months. Each participant will attend 1 baseline visit, 1 enrollment visit, and 4 treatment visits over a period of approximately 4 weeks. Following the baseline visit, participant eligibility will be determined. The enrollment visit will be scheduled on the same day as the first treatment visit. The following feasibility data will be collected: * \# of participants recruited * \# of participants consented * \# of participants enrolled * \# of participants who completed the study * Total duration of the study from launch data to the final study visit

Interventions

OTHERHVLA-SM

High velocity, low amplitude spinal manipulation

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
University of Iowa
CollaboratorOTHER
Palmer College of Chiropractic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age 21-65 * Signed informed consent document * Chronic (12+ weeks) low back pain (LBP) * Average pain within past 24 hours ≥ 2/10 at phone screen, baseline visit 1, and baseline visit 2

Exclusion criteria

* Compliance concerns such as refusal to shave body hair * No manipulable lesion in L3, L4, L5 or SI joints (The absence of typical palpatory characteristics as well as the absence of a global assessment that would indicate that spinal manipulation is likely to generate a positive therapeutic effect, even without the presence of standard palpatory findings) * Comorbid Conditions: * Serious Contaminant Illness * Inflammatory or Destructive Spinal Tissue change * Ankylosing Spondylitis * Fibromyalgia * Rheumatoid Arthritis * Neuromuscular Disease (e.g. Parkinson's, Muscular Dystrophy, Cerebral Palsy, or Myasthenia gravis) * Spinal Surgery \< 6 mo * Suspicion of drug or alcohol abuse * Uncontrolled hypertension * Peripheral Arterial Disease * Undetermined, infectious or visceral source of LBP * Other comorbid conditions prohibiting treatment and/or testing * Safety Concerns * Bleeding Disorders * Contraindications to HVLA-SM * Quebec Task Force (QTF) criterion 4-11: * QTF 4: Pain + radiation to upper/lower limb with signs * QTF 5: Presumptive compression of a spinal nerve root on a simple roentgenogram * QTF 6: Compression of a spinal nerve root confirmed by specific imaging techniques * QTF 7: Spinal Stenosis * QTF 8: Postsurgical status, 1-6 months after intervention * QTF 9: Postsurgical status, \>6 months after intervention * QTF 10: Chronic pain syndrome * QTF 11: Other diagnoses * Pregnancy * Pacemaker or defibrillator * Inability to read or verbally comprehend English * Joint Replacement * Sensitivity to adhesive * Additional diagnostic procedures other than x-ray necessary * BDI-II \> 29 * Retention of legal advice and open or pending case related to LBP * BMI \> 40 * Unwilling to have low back and wrist shaved * Seeking or receiving compensation for any disability?

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of Conducting a Full-scale Randomized Control Trial to Evaluate Patient Response to Spinal Manipulation: Number of Participants Who Were Recruited, Consented, Enrolled, and Completed the StudyApproximately 4-6 weeks including initial eligibility screening, baseline visits, and 2 weeks of treatment visitsFeasibility was measured by the numbers of participants: recruited, consented, enrolled, and retained. This pilot study allowed for testing of equipment, finalizing the data collection protocol, and training study personnel before conducting the full-scale trial.
Feasibility of Conducting a Full-scale Randomized Control Trial to Evaluate Patient Response to Spinal Manipulation: Study Duration.Approximately 4-6 weeks including initial eligibility screening, baseline visits, and 2 weeks of treatment visitsFeasibility was measured by the study duration from study launch to collection of final study outcomes. This pilot study allowed for testing of equipment, finalizing the data collection protocol, and training study personnel before conducting the full-scale trial.

Countries

United States

Participant flow

Participants by arm

ArmCount
HVLA-SM
High velocity, low amplitude lumbo-pelvic manipulation HVLA-SM: High velocity, low amplitude spinal manipulation
6
Total6

Baseline characteristics

CharacteristicHVLA-SM
Age, Continuous53 years
STANDARD_DEVIATION 10.5
Race/Ethnicity, Customized
Other
1 Participants
Race/Ethnicity, Customized
White
5 Participants
Region of Enrollment
United States
6 participants
Sex: Female, Male
Female
1 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 6
other
Total, other adverse events
0 / 6
serious
Total, serious adverse events
0 / 6

Outcome results

Primary

Feasibility of Conducting a Full-scale Randomized Control Trial to Evaluate Patient Response to Spinal Manipulation: Number of Participants Who Were Recruited, Consented, Enrolled, and Completed the Study

Feasibility was measured by the numbers of participants: recruited, consented, enrolled, and retained. This pilot study allowed for testing of equipment, finalizing the data collection protocol, and training study personnel before conducting the full-scale trial.

Time frame: Approximately 4-6 weeks including initial eligibility screening, baseline visits, and 2 weeks of treatment visits

ArmMeasureGroupValue (NUMBER)
Feasibility OutcomesFeasibility of Conducting a Full-scale Randomized Control Trial to Evaluate Patient Response to Spinal Manipulation: Number of Participants Who Were Recruited, Consented, Enrolled, and Completed the Study# Participants Recruited19 participants
Feasibility OutcomesFeasibility of Conducting a Full-scale Randomized Control Trial to Evaluate Patient Response to Spinal Manipulation: Number of Participants Who Were Recruited, Consented, Enrolled, and Completed the Study# Participants Consented9 participants
Feasibility OutcomesFeasibility of Conducting a Full-scale Randomized Control Trial to Evaluate Patient Response to Spinal Manipulation: Number of Participants Who Were Recruited, Consented, Enrolled, and Completed the Study# Participants Enrolled6 participants
Feasibility OutcomesFeasibility of Conducting a Full-scale Randomized Control Trial to Evaluate Patient Response to Spinal Manipulation: Number of Participants Who Were Recruited, Consented, Enrolled, and Completed the Study# Participants Completed6 participants
Primary

Feasibility of Conducting a Full-scale Randomized Control Trial to Evaluate Patient Response to Spinal Manipulation: Study Duration.

Feasibility was measured by the study duration from study launch to collection of final study outcomes. This pilot study allowed for testing of equipment, finalizing the data collection protocol, and training study personnel before conducting the full-scale trial.

Time frame: Approximately 4-6 weeks including initial eligibility screening, baseline visits, and 2 weeks of treatment visits

ArmMeasureValue (NUMBER)
Feasibility OutcomesFeasibility of Conducting a Full-scale Randomized Control Trial to Evaluate Patient Response to Spinal Manipulation: Study Duration.4 months

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026